Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
InhaleRx Limited (AU:IRX)
ASX:IRX
Holding AU:IRX?
Track your performance easily
IRX Stock Chart & Stats
Day’s Range― - ―
52-Week RangeAU$0.01 - AU$0.06
Previous CloseN/A
Volume3.50K
Average Volume (3M)38.15K
Market Cap
AU$5.34M
Enterprise ValueAU$4.73M
Total Cash (Recent Filing)$4.52M
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.18
Next Earnings
Feb 24, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding213,448,230
10 Day Avg. Volume17,380
30 Day Avg. Volume38,148
Standard Deviation0.25
R-Squared0.04
Alpha0.03
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)314.00
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market Cap0.89
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit190.73
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
InhaleRx Limited News
PremiumCompany Announcements
InhaleRx Advances with Funding and Market Opportunities
PremiumCompany Announcements
InhaleRx Director Acquires Shares Amid Strategic Adjustments
PremiumCompany Announcements
InhaleRx Director Sean Williams Increases ShareholdingPremiumCompany Announcements
InhaleRx Limited Reports Expiry of 500,000 Options
PremiumCompany Announcements
InhaleRx Limited Secures Shareholder Support for Growth
PremiumCompany Announcements
InhaleRx Limited Plans Key Discussions at General Meeting
PremiumCompany Announcements
InhaleRx Appoints New Director Amid Strategic Growth
PremiumCompany Announcements
InhaleRx Advances Non-Opioid Cancer Pain Treatment TrialsOptions Prices
Currently, No data available
---
Ownership Overview
IRX FAQ
What was InhaleRx Limited’s price range in the past 12 months?
InhaleRx Limited lowest share price was AU$0.01 and its highest was AU$0.06 in the past 12 months.
What is InhaleRx Limited’s market cap?
InhaleRx Limited’s market cap is AU$5.34M.
When is InhaleRx Limited’s upcoming earnings report date?
InhaleRx Limited’s upcoming earnings report date is Feb 24, 2025 which is in 36 days.
How were InhaleRx Limited’s earnings last quarter?
InhaleRx Limited released its earnings results on Aug 30, 2024. The company reported -AU$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -AU$0.004.
Is InhaleRx Limited overvalued?
According to Wall Street analysts InhaleRx Limited’s price is currently Overvalued.
Does InhaleRx Limited pay dividends?
InhaleRx Limited does not currently pay dividends.
What is InhaleRx Limited’s EPS estimate?
InhaleRx Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does InhaleRx Limited have?
InhaleRx Limited has 213,448,230 shares outstanding.
What happened to InhaleRx Limited’s price movement after its last earnings report?
InhaleRx Limited reported an EPS of -AU$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of InhaleRx Limited?
Currently, no hedge funds are holding shares in AU:IRX
---
InhaleRx Limited Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
8.00%
12-Months-Change
Fundamentals
Return on Equity
-252.23%
Trailing 12-Months
Asset Growth
-48.07%
Trailing 12-Months
Company Description
InhaleRx Limited
InhaleRx Ltd focuses on medical inhalation devices for the delivery of prescribed medicines. The Medihale Inhaler utilizes heat (not burn) technology, avoiding the production of pyrolytic toxins and carcinogenics often created when combusting plant material such as tobacco or cannabis leafs of flowers. The sealed tamper proof Medihale Pods provide patients with the additional security that the Medical Cannabis c-liquid is of good quality.
---
Technical Analysis
Althea Group Holdings Ltd.
―
Race Oncology Ltd.
―
Alcidion Group Limited
―
dorsaVi Limited
―
---